List of Tables
Table 1. Global Testosterone Replacement Injectables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Testosterone Replacement Injectables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Testosterone Replacement Injectables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Testosterone Replacement Injectables Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Testosterone Replacement Injectables Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Testosterone Replacement Injectables Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Testosterone Replacement Injectables Sales by Region (2020-2025) & (K Units)
Table 8. Global Testosterone Replacement Injectables Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Testosterone Replacement Injectables Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Testosterone Replacement Injectables Sales Share by Manufacturers (2020-2025)
Table 12. Global Testosterone Replacement Injectables Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Testosterone Replacement Injectables Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Testosterone Replacement Injectables by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Replacement Injectables as of 2024)
Table 16. Global Testosterone Replacement Injectables Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Testosterone Replacement Injectables Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Testosterone Replacement Injectables Manufacturing Base and Headquarters
Table 19. Global Testosterone Replacement Injectables Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Testosterone Replacement Injectables Sales by Type (2020-2025) & (K Units)
Table 23. Global Testosterone Replacement Injectables Sales by Type (2026-2031) & (K Units)
Table 24. Global Testosterone Replacement Injectables Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Testosterone Replacement Injectables Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Testosterone Replacement Injectables ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Testosterone Replacement Injectables Sales by Application (2020-2025) & (K Units)
Table 29. Global Testosterone Replacement Injectables Sales by Application (2026-2031) & (K Units)
Table 30. Testosterone Replacement Injectables High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Testosterone Replacement Injectables Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Testosterone Replacement Injectables Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Testosterone Replacement Injectables ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Testosterone Replacement Injectables Growth Accelerators and Market Barriers
Table 37. North America Testosterone Replacement Injectables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Testosterone Replacement Injectables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Testosterone Replacement Injectables Growth Accelerators and Market Barriers
Table 40. Europe Testosterone Replacement Injectables Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Testosterone Replacement Injectables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Testosterone Replacement Injectables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Testosterone Replacement Injectables Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Testosterone Replacement Injectables Growth Accelerators and Market Barriers
Table 45. Southeast Asia Testosterone Replacement Injectables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Testosterone Replacement Injectables Investment Opportunities and Key Challenges
Table 47. Central and South America Testosterone Replacement Injectables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Testosterone Replacement Injectables Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Testosterone Replacement Injectables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Marius Pharmaceuticals Corporation Information
Table 51. Marius Pharmaceuticals Description and Major Businesses
Table 52. Marius Pharmaceuticals Product Models, Descriptions and Specifications
Table 53. Marius Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Marius Pharmaceuticals Sales Value Proportion by Product in 2024
Table 55. Marius Pharmaceuticals Sales Value Proportion by Application in 2024
Table 56. Marius Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 57. Marius Pharmaceuticals Testosterone Replacement Injectables SWOT Analysis
Table 58. Marius Pharmaceuticals Recent Developments
Table 59. Insud Pharma S.L Corporation Information
Table 60. Insud Pharma S.L Description and Major Businesses
Table 61. Insud Pharma S.L Product Models, Descriptions and Specifications
Table 62. Insud Pharma S.L Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Insud Pharma S.L Sales Value Proportion by Product in 2024
Table 64. Insud Pharma S.L Sales Value Proportion by Application in 2024
Table 65. Insud Pharma S.L Sales Value Proportion by Geographic Area in 2024
Table 66. Insud Pharma S.L Testosterone Replacement Injectables SWOT Analysis
Table 67. Insud Pharma S.L Recent Developments
Table 68. AbbVie Inc Corporation Information
Table 69. AbbVie Inc Description and Major Businesses
Table 70. AbbVie Inc Product Models, Descriptions and Specifications
Table 71. AbbVie Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. AbbVie Inc Sales Value Proportion by Product in 2024
Table 73. AbbVie Inc Sales Value Proportion by Application in 2024
Table 74. AbbVie Inc Sales Value Proportion by Geographic Area in 2024
Table 75. AbbVie Inc Testosterone Replacement Injectables SWOT Analysis
Table 76. AbbVie Inc Recent Developments
Table 77. Acrux Ltd Corporation Information
Table 78. Acrux Ltd Description and Major Businesses
Table 79. Acrux Ltd Product Models, Descriptions and Specifications
Table 80. Acrux Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Acrux Ltd Sales Value Proportion by Product in 2024
Table 82. Acrux Ltd Sales Value Proportion by Application in 2024
Table 83. Acrux Ltd Sales Value Proportion by Geographic Area in 2024
Table 84. Acrux Ltd Testosterone Replacement Injectables SWOT Analysis
Table 85. Acrux Ltd Recent Developments
Table 86. Besins Healthcare SA Corporation Information
Table 87. Besins Healthcare SA Description and Major Businesses
Table 88. Besins Healthcare SA Product Models, Descriptions and Specifications
Table 89. Besins Healthcare SA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Besins Healthcare SA Sales Value Proportion by Product in 2024
Table 91. Besins Healthcare SA Sales Value Proportion by Application in 2024
Table 92. Besins Healthcare SA Sales Value Proportion by Geographic Area in 2024
Table 93. Besins Healthcare SA Testosterone Replacement Injectables SWOT Analysis
Table 94. Besins Healthcare SA Recent Developments
Table 95. Pfizer Inc Corporation Information
Table 96. Pfizer Inc Description and Major Businesses
Table 97. Pfizer Inc Product Models, Descriptions and Specifications
Table 98. Pfizer Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Pfizer Inc Recent Developments
Table 100. Acerus Pharmaceuticals Corporation Corporation Information
Table 101. Acerus Pharmaceuticals Corporation Description and Major Businesses
Table 102. Acerus Pharmaceuticals Corporation Product Models, Descriptions and Specifications
Table 103. Acerus Pharmaceuticals Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Acerus Pharmaceuticals Corporation Recent Developments
Table 105. Amneal Pharmaceuticals Inc Corporation Information
Table 106. Amneal Pharmaceuticals Inc Description and Major Businesses
Table 107. Amneal Pharmaceuticals Inc Product Models, Descriptions and Specifications
Table 108. Amneal Pharmaceuticals Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Amneal Pharmaceuticals Inc Recent Developments
Table 110. Biote Medical LLC Corporation Information
Table 111. Biote Medical LLC Description and Major Businesses
Table 112. Biote Medical LLC Product Models, Descriptions and Specifications
Table 113. Biote Medical LLC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Biote Medical LLC Recent Developments
Table 115. Endo International Plc Corporation Information
Table 116. Endo International Plc Description and Major Businesses
Table 117. Endo International Plc Product Models, Descriptions and Specifications
Table 118. Endo International Plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Endo International Plc Recent Developments
Table 120. Eli lilly Corporation Information
Table 121. Eli lilly Description and Major Businesses
Table 122. Eli lilly Product Models, Descriptions and Specifications
Table 123. Eli lilly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Eli lilly Recent Developments
Table 125. Actavis (Allergan) Corporation Information
Table 126. Actavis (Allergan) Description and Major Businesses
Table 127. Actavis (Allergan) Product Models, Descriptions and Specifications
Table 128. Actavis (Allergan) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Actavis (Allergan) Recent Developments
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Major Businesses
Table 132. Bayer Product Models, Descriptions and Specifications
Table 133. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Bayer Recent Developments
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Major Businesses
Table 137. Novartis Product Models, Descriptions and Specifications
Table 138. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Novartis Recent Developments
Table 140. Teva Corporation Information
Table 141. Teva Description and Major Businesses
Table 142. Teva Product Models, Descriptions and Specifications
Table 143. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Teva Recent Developments
Table 145. Mylan Corporation Information
Table 146. Mylan Description and Major Businesses
Table 147. Mylan Product Models, Descriptions and Specifications
Table 148. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Mylan Recent Developments
Table 150. Upsher-Smith Corporation Information
Table 151. Upsher-Smith Description and Major Businesses
Table 152. Upsher-Smith Product Models, Descriptions and Specifications
Table 153. Upsher-Smith Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Upsher-Smith Recent Developments
Table 155. Ferring Pharmaceuticals Corporation Information
Table 156. Ferring Pharmaceuticals Description and Major Businesses
Table 157. Ferring Pharmaceuticals Product Models, Descriptions and Specifications
Table 158. Ferring Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Ferring Pharmaceuticals Recent Developments
Table 160. Kyowa Kirin Corporation Information
Table 161. Kyowa Kirin Description and Major Businesses
Table 162. Kyowa Kirin Product Models, Descriptions and Specifications
Table 163. Kyowa Kirin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Kyowa Kirin Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Testosterone Replacement Injectables Product Picture
Figure 2. Global Testosterone Replacement Injectables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Testosterone Undecanoate Product Picture
Figure 4. Testosterone Cypionate Product Picture
Figure 5. Testosterone Enanthate Product Picture
Figure 6. Others Product Picture
Figure 7. Global Testosterone Replacement Injectables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Others
Figure 11. Testosterone Replacement Injectables Report Years Considered
Figure 12. Global Testosterone Replacement Injectables Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 14. Global Testosterone Replacement Injectables Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Testosterone Replacement Injectables Revenue Market Share by Region (2020-2031)
Figure 16. Global Testosterone Replacement Injectables Sales (2020-2031) & (K Units)
Figure 17. Global Testosterone Replacement Injectables Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Testosterone Replacement Injectables Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Testosterone Replacement Injectables Sales Volume Market Share in 2024
Figure 20. Global Testosterone Replacement Injectables Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Testosterone Undecanoate Revenue Market Share by Manufacturer in 2024
Figure 23. Testosterone Cypionate Revenue Market Share by Manufacturer in 2024
Figure 24. Testosterone Enanthate Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global Testosterone Replacement Injectables Sales Market Share by Type (2020-2031)
Figure 27. Global Testosterone Replacement Injectables Revenue Market Share by Type (2020-2031)
Figure 28. Global Testosterone Replacement Injectables Sales Market Share by Application (2020-2031)
Figure 29. Global Testosterone Replacement Injectables Revenue Market Share by Application (2020-2031)
Figure 30. North America Testosterone Replacement Injectables Sales YoY (2020-2031) & (K Units)
Figure 31. North America Testosterone Replacement Injectables Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Testosterone Replacement Injectables Sales Revenue (US$ Million) in 2024
Figure 33. North America Testosterone Replacement Injectables Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Testosterone Replacement Injectables Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Testosterone Replacement Injectables Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Testosterone Replacement Injectables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Testosterone Replacement Injectables Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Testosterone Replacement Injectables Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Testosterone Replacement Injectables Sales Revenue (US$ Million) in 2024
Figure 43. Europe Testosterone Replacement Injectables Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Testosterone Replacement Injectables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Testosterone Replacement Injectables Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Testosterone Replacement Injectables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 48. France Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Testosterone Replacement Injectables Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Testosterone Replacement Injectables Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Testosterone Replacement Injectables Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Testosterone Replacement Injectables Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Testosterone Replacement Injectables Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Testosterone Replacement Injectables Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Testosterone Replacement Injectables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 63. India Testosterone Replacement Injectables Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Testosterone Replacement Injectables Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Testosterone Replacement Injectables Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Testosterone Replacement Injectables Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Testosterone Replacement Injectables Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Testosterone Replacement Injectables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Testosterone Replacement Injectables Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Testosterone Replacement Injectables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Testosterone Replacement Injectables Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Testosterone Replacement Injectables Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Testosterone Replacement Injectables Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Testosterone Replacement Injectables Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Testosterone Replacement Injectables Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Testosterone Replacement Injectables Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Testosterone Replacement Injectables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Testosterone Replacement Injectables Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Testosterone Replacement Injectables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Testosterone Replacement Injectables Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Testosterone Replacement Injectables Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Testosterone Replacement Injectables Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Testosterone Replacement Injectables Revenue (2020-2025) & (US$ Million)
Figure 84. Testosterone Replacement Injectables Industry Chain Mapping
Figure 85. Regional Testosterone Replacement Injectables Manufacturing Base Distribution (%)
Figure 86. Global Testosterone Replacement Injectables Production Market Share by Region (2020-2031)
Figure 87. Testosterone Replacement Injectables Production Process
Figure 88. Regional Testosterone Replacement Injectables Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
